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Editors: Anton N. Sidawy and Bruce A. PerlerIn situ laser fenestration during emergent thoracic
endovascular aortic repair is an effective method for left
subclavian artery revascularization
Richard E. Redlinger, Sadaf S. Ahanchi, and Jean M. Pan-
neton, Norfolk, Va
Background: Retrograde laser fenestration of the left sub-
clavian artery (LSA) during emergent thoracic endovascular
aortic repair (TEVAR) uses a relatively simple intraoperative
method of endograft modiﬁcation to revascularize aortic
branches for a varietyof acute thoracic aortic pathologies.This
study presents our expanded experience and midterm out-
comes of TEVAR with laser fenestration to revascularize the
LSA as an alternative to debranching.
Methods: Patients who underwent TEVAR with LSA
revascularization by laser graft fenestration from September
2009 through August 2012 were retrospectively reviewed.
TEVAR was performed with deployment of a Dacron
(DuPont, Wilmington, Del) endograft over the LSA oriﬁce.
Laser catheter fenestration of the graft was performed
through retrograde brachial access, followed by balloon-
expandable covered stent deployment through the fenes-
tration to traverse the endograft and LSA. Routine post-
operative follow-up imaging with computed tomography
angiography was performed to assess TEVAR and LSA fen-
estration patency, endoleak, and aneurysm/dissection
exclusion.
Results: TEVAR with laser fenestration was successfully
performed in 22 patients (12 men; mean age, 57 years) in
an urgent or emergent setting secondary to unremitting
symptoms or rupture. Twelve patients had large symp-
tomatic thoracic aortic aneurysms (eight secondary to
chronic dissection); four patients had acute symptomatic
type B aortic dissection, and six patients had an intramural
hematoma or penetrating aortic ulcer, or both. An average
of two endografts (range, 1-4) were deployed. LSA-covered
stents were 8 to 10 mm in diameter. Mean operative time
was 154  65 minutes. Average hospital length of stay was
12  7 days. No major fenestration-related complications
occurred. One patient developed postoperative paraplegia.
One patient died in the postoperative period, for an in-
hospital mortality rate of 4.5%. Two patients died of non-
TEVAR-related causes at a mean follow-up of 10 months
(range, 1-40 months). Follow-up computed tomography
angiography imaging demonstrated a 100% primary patency
for the LSA stents. One patient had an asymptomatic LSA*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(13)00615-1stent stenosis. Type II endoleaks from the LSA in two pa-
tients required endovascular coil embolization. No fenes-
tration-related type I or III endoleaks were noted.
Conclusions: In situ retrograde laser fenestration is a fea-
sible and effective option for LSA revascularization during
TEVAR involving a spectrum of acute thoracic aortic pa-
thology. Laser fenestration provides a rapid, reproducible
method of fenestrating the endograft material. The high
technical success, low fenestration-related morbidity, and
excellent midterm patency support this technique of intra-
operative endograft modiﬁcation.The management of endograft infections following
endovascular thoracic and abdominal aneurysm repair
Erin H. Murphy, Wilson Y. Szeto, Benjamin J. Herdrich,
Benjamin M. Jackson, Grace J. Wang, Joseph E. Bavaria,
Ronald M. Fairman, and Edward Y. Woo
Objective: Themanagement of infected aortic endografts is
a challenging endeavor. Treatment of this problem has not
been well deﬁned as it is fairly uncommon. However, the
incidence is increasing. This study examines the results of
treatment at a single center for this morbid process.
Methods: A retrospective review was performed of pa-
tients treated for infected abdominal or thoracic endograft
infection following previous abdominal or thoracic endovas-
cular aneurysm repair. Data was reviewed for patient de-
mographics, details of initial endograft implantation,
presentation and timeline of subsequent infection, man-
agement of infected grafts, and outcomes during follow-up.
Results: Overall, 18 patients were treated for infected
endografts (thoracic: six, abdominal:12). Three patients
were treated between 2000 and 2006, corresponding to
a 0.6% institutional incidence of endograft infection (3/
473). There were no transfers for infected endografts from
outside institutions. From 2006 to 2011, 15 patients un-
derwent treatment. Six were institutional cases of infections
(6/945, 0.6% infection rate), however, there was an increase
in transfers (n ¼ 9). Median time to presentation with
infection from endograft implant was 90 days, with over
one-half (61%) presenting within the ﬁrst 3 months. Tissue
and/or blood cultures were positive in 12/16 growing
Escherichia coli (n ¼ 1), group A streptococcus (n ¼ 3),
methicillin-resistant Staphylococcus aureus (n ¼ 3), or
polymicrobial infections (n ¼ 7). The other four patients
were culture negative with computed tomography evidence
of gas surrounding the endograft and clinical sepsis. Ten
patients (abdominal: eight, thoracic: two) were treated with
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considered too high-risk for explant or refused open surgery
and were therefore managed conservatively without
explant (abdominal: four, thoracic: four). At a mean follow-
up of 24.7 months, aneurysm-related mortality was 38.9%
(n¼7) and was higher for patients presenting with
aortoenteric or aortobronchial ﬁstulas (n ¼ 6/10, 60%) (P ¼
.04) and for thoracic stent infections (n [ 5/6; 83%) (P ¼ .03).
The only survivor of a thoracic infection was managed
surgically. Overall survival for patients with abdominal
endografts (n ¼ 12) was similar between the eight patients
managed surgically (n [ 6/8; 75%) and the four selected for
medical management (n ¼ 4/4; 100%) (P ¼ .39). All survi-
vors remain on long-term suppressive antibiotics. Two
additional patients died of unrelated causes during follow-
up.
Conclusions: Endograft infection is a rare but increasing
complication after abdominal or thoracic endovascular
aneurysm repair, which carries signiﬁcant associated mor-
bidity and mortality. Most endograft infections occurred in
proximity to other types of infection, suggesting that bac-
terial seeding of the endograft was the source. Aortoenteric
and aortobronchial ﬁstulas are common presentations,
which portend a signiﬁcantly worse prognosis. Thoracic
endograft infections, which have the highest rate of ﬁstu-
lization, have the worst outcomes. Surgical excision con-
tinues to be standard of care but conservative management
with intravenous antibiotics may be of beneﬁt in certain
patients with abdominal endograft infections.The fate of untreated concomitant suprarenal aortic
aneurysms after endovascular aneurysm repair of
infrarenal aortic aneurysms
Benjamin J. Herdrich, Erin H. Murphy, Grace J. Wang, Ben-
jamin M. Jackson, Ronald M. Fairman, and Edward Y. Woo
Objective: Many patients treated with endovascular
aortic repair (EVAR) have a concomitant suprarenal
abdominal aortic aneurysm (sAAA). The natural history of
these sAAAs and whether they require intervention after
EVAR is unknown.
Methods: We identiﬁed 470 patients from the M2S
database (M2S Inc, West Lebanon, NH) as having an
infrarenal AAA (iAAA) with a concomitant sAAA (diameter,
2.9-4.7 cm). The analysis included 217 patients with pre-
operative computed tomography angiography and follow-
up imaging of ≥12 months. Patients who did not undergo
EVAR (n = 65) served as a control. Patients with EVAR were
subdivided into 90 with suprarenal ﬁxation (SR) and 62 with
infrarenal ﬁxation (IR). Standard measurements from the
M2S images were extracted, and growth rates were calcu-
lated for different abdominal aortic segments.
Results: The average follow-up was 33.0 ± 18.8 months.
The average sAAA initial size and growth rate were 34.6 ±
3.0 and 0.6 ± 1.1 mm/y for SR, 34.0 ± 3.3 and 0.6 ± 1.3 mm/
y for IR, and 36.6 ± 3.4 and 1.2 ± 1.5 mm/y for controls (SR
vs IR, P > .05; SR or IR vs control, P < .05). After EVAR, twoof 152 (1.3%) sAAAs grew to ≥50 mm, which was not sta-
tistically different from four of 65 (6.2%) in the control
group (P = .07). At 48 months, the Kaplan-Meier freedom
from sAAA growth to ≥50 mm was 99.3% for patients un-
dergoing EVAR and 95.2% for controls (P = .061). Patients
with starting sAAAs sized ≥40 mm had a higher growth rate
(1.4 ± 2.1 mm/y) and frequency of growth to ≥50 mm
(14.3%) than patients with starting sAAAs sized <40 mm
(0.7 ± 1.2 mm/y and 1.5%; P < .05).
Conclusions: Isolated treatment of iAAAs via EVAR with
a concomitant sAAA is acceptable because endografts with
or without SR do not affect sAAA growth rates. Routine
EVAR follow-up is sufﬁcient for sAAAs of <40 mm, and
more intensive follow-up should be considered for sAAAs of
40 to 50 mm. For sAAAs approaching 50 mm, an endograft
with IR should be considered in case sAAA repair is required
in the future.Predisposing factors, management, and prognostic
evaluation of acute carotid blowout syndrome
Hsueh-Ju Lu, Kuo-Wei Chen, Ming-Huang Chen, Pen-Yuan
Chu, Shyh-Kuan Tai, Ling-Wei Wang, Peter Mu-Hsin Chang,
Muh-Hwa Yang
Objective: Massive hemorrhages occur in 6%-10% of pa-
tients with advanced cancer. Acute carotid blowout syn-
drome is the most severe massive hemorrhagic
complication in head and neck cancer patients..
Methods: This was a single institute, retrospective,
case control study. A total of 45 patients were enrolled
in this study. The predisposing factors, management, and
prognosis of acute carotid blowout syndrome were
evaluated.
Results: Among the baseline characteristics, the site of
the primary tumor (P = .003), origin of bleeding (P = .048),
method of intervention (P = .005), and time to intervention
(P = .006) were signiﬁcantly different factors between sur-
vivor and nonsurvivor patients. After 24 hours of onset,
a Glasgow Coma Scale score (P = .000), the use of inotropic
agents (P = .007), and neutrophil-to-lymphocyte ratio (P =
.019) were signiﬁcantly predicting factors for outcome.
Multivariate logistic regression analyses revealed bleeding
from common carotid artery was an independent factor for
long-term survival (odds ratio, 25.951; 95% conﬁdence in-
terval [CI], 1.373-490.441; P < .030). The median overall
survival of survivors and nonsurvivors were 12.1 (range, 3.7-
118.7; 95% CI, 4.33-54.87) and 11.9 (range, 0.7-53.5; 95%
CI, 5.78-25.69) months, respectively (P = .092).
Conclusions: Early and aggressive intervention is impor-
tant for the successful management of acute carotid
blowout syndrome. The Glasgow Coma Scale score, the use
of inotropic agents, and neutrophil-to-lymphocyte ratio 24
hours after the onset were predictive factors for patients'
outcomes. Bleeding from common carotid artery is an in-
dependent prognostic factor in multivariate analysis. Long-
term survival can be achieved after successful
management.
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collateral artery development in patients with intermittent
claudication during supervised exercise therapy
Bas Versluis, Tim Leiner, Patty J. Nelemans, Joachim E.
Wildberger, Geert-Willem Schurink, Walter H. Backes
Objective: The purpose of the current study was to
determine whether supervised exercise therapy (SET) leads
to measurable vascular adaptations in patients with
intermittent claudication using contrast-enhanced mag-
netic resonance angiography and ﬂow measurements.
Methods: Ten patients with clinical symptoms of inter-
mittent claudication and proven obstructive arterial lesions
of the superﬁcial femoral artery were included and under-
went SET for a period of 6 months. At baseline, all patients
underwent a treadmill test to assess pain free walking dis-
tance, ankle brachial index measurement, and magnetic
resonance imaging to determine the number of arteries in
the upper leg using contrast-enhanced magnetic resonance
angiography and arterial peak ﬂow in the popliteal artery
using cine phase contrast angiography. All examinations
were repeated after 3 and 6 months of SET, respectively, to
evaluate vascular responses relative to baseline.
Results: After 6 months of SET, mean pain free walking
distance (395  46 m) was improved by 71% compared
with baseline (230  42 m; P < .01). No statistically sig-
niﬁcant changes were found for mean values of ankle bra-
chial index (81  4 and 77  4, respectively, at baseline and
after 6 months of SET), number of arteries at the level of
the arterial lesion (18  2 and 19  2, respectively) nor
arterial peak ﬂow (5.3  0.6 and 5.3  0.8 mL/s,
respectively).
Conclusions: SET in patients with intermittent claudica-
tion results in an increase in pain free walking distance,
whereas with magnetic resonance imaging no macro-
vascular adaptations in terms of additional collateral artery
formation or ﬂow increases could be observed.Hypertensive extracorporeal limb perfusion for critical
limb ischemia
Nyan Y. Khin, BE, Martijn L. Dijkstra, Matt Huckson, Meng,
Mark Phillips, Darryl McMillan, CCP, Seiji Itoh, Greg Roger,
Rodney J. Lane
Objective: This article reports the early results in humans
of hypertensive extracorporeal limb perfusion (HELP) tech-
nology in the prevention of major limb amputation due to
ischemia. The short-term aim was to dilate pre-existing
collateral channels, and the long-term aim was to stimulate
remodeling and new collateral development by increasing
endothelial shear stress and wall tension.
Methods: This study evaluated 20 patients with critical
limb ischemia who were treated with HELP. These patients
had no other option but major amputation, as determined
by at least two vascular surgeons. The arterial circulation to
the ischemic limb was isolated from the systemic circulation
by the use of an endoluminal balloon catheter in sevenpatients and by an implantable, inﬂatable, occlusive cuff in
13. The limbs were hyperperfused through the peripheral
access system with an extracorporeal pump, producing
a minimally pulsatile waveform at 200% to 300% of the
mean arterial pressure. This was performed repeatedly in
sessions of 24 to 36 hours, up to a maximum of 74 hours.
The primary end point was avoidance of major amputation.
The secondary end points were the clinical improvements in
rest pain, ulcer healing, and claudication distance. Patients
were analyzed and reviewed using infrared thermography
and ultrasound imaging parameters of the limb
Results: Given adequate arterial access, 39 of 40 con-
nections developed ﬂows four to eight times those supplied
to the limb by the normal cardiac output. A progressive
decrease was noted in peripheral resistance. All patients
developed a pain-free, warm foot or hand while on the
pump in the short-term. In the longer term at a mean of 22
months (range, 12-54 months), eight of 20 patients (40%)
had avoided major amputation and four more had a delay in
amputation of an average of 4 months. The ankle-brachial
index changed from 0.04 ± 0.07 (range, 0.00-0.94) to 0.63 ±
0.39 (t-test, P < .05). Bleeding, infection, premature ces-
sation of the treatment, and poor patient selection resulted
in the failures. There were two short-term unrelated deaths
that occurred at 1 and 3 months follow-up.
Conclusions: The collateral circulation of ischemic limbs
can be augmented and regulated by a connection to an
extracorporeal centrifugal pump, with isolation from the
systemic circulation provided by balloons and with an ac-
cess system providing repeatable pump connections. Major
amputation may be avoided in selected cases.The prognosis of patients on hemodialysis with foot
lesions
Yuki Orimoto, Takashi Ohta, Hiroyuki Ishibashi, Ikuo Sugi-
moto, Hirohide Iwata, Tetsuya Yamada, Masao Tadakoshi,
and Noriyuki Hida
Objective: Many studies have shown the high prevalence
and incidence of peripheral arterial disease and the marked
morbidity and mortality associated with peripheral arterial
disease in hemodialysis patients. The purpose of this ret-
rospective study was to clarify the probability of survival
and limb salvage in patients with foot lesions and how to
manage these patients.
Methods: Data were collected in a retrospectively main-
tained database for 319 lower limbs with foot lesions in 234
hemodialysis patients treated in a university hospital be-
tween 1980 and 2011. Variances inﬂuencing survival and
limb salvage were compared using log-rank tests and Cox
regression analysis. These variables were examined using
Kaplan-Meier analysis. Signiﬁcant factors in bivariate anal-
ysis were included in a logistic regression model to deter-
mine independent predictors and the probability of failure.
Results: The 234 patients (72% men) were a mean age of
65.4 years on admission, and 84% had diabetes. The mean
606 Abstractsduration of hemodialysis was 6.8 years. During the follow-up
period, 171 patients (73%) died. The 1-, 3-, 5-, and 7-year sur-
vival rates were 65.2%, 35.5%, 23.4%, and 12.8%, respectively.
According to Cox multivariate models, age at admission and
ischemic changes on an electrocardiogram independently
increased the risk of death (hazard ratios, 1.02 and 1.48,
respectively). Conversely, hyperlipidemia independently
decreased the risk of death (hazard ratio, 0.56). Critical limb
ischemia was present in 247 limbs (77%). Arterial recon-
struction was done in 88 limbs (28%), and 119 limbs (37%)
required major amputation. The overall 1-, 3-, 5- and 7-year
limb salvage rates were 68.9%, 57.2%, 53.8%, and 51.7 %,
respectively. According to Cox multivariate models, patent
arterial reconstruction and albumin independently decreased
the risk of major amputation (hazard ratios, 0.265 and 0.392,
respectively).
Conclusions: Hemodialysis patients with foot lesions have
a poor prognosis, with high rates of mortality and amputa-
tion. Prompt assessments of the severity of systemic condi-
tions, such as cardiac ischemia, and focal wound conditions,
such as ischemia and infection, are necessary to treat he-
modialysis patients with foot lesions.The rise and fall of renal artery angioplasty and stenting in
the United States, 1988-2009
Patric Liang, BA, Rob Hurks, Rodney P. Bensley, Allen
Hamdan, Mark Wyers, Elliot Chaikof, and Marc L.
Schermerhorn
Objective: Optimal management of renal artery stenosis
(RAS) remains unclear. Recent randomized controlled trials
have shown no clear beneﬁt with percutaneous trans-
luminal angioplasty with or without stenting (PTRA/S) over
medical management. We hypothesize that interventions
for RAS are decreasing nationally.
Methods: The Nationwide Inpatient Sample, 1988-2009,
was used to identify patients with a diagnosis of renal ar-tery atherosclerosis undergoing open surgical repair (bypass
or endarterectomy) or PTRA/S. The rate of interventions, in-
hospital death, and perioperative outcomes were analyzed
over time. Additionally, we used individual state inpatient
and ambulatory databases to better understand the inﬂu-
ence of outpatient procedures on current volume and
trends..
Results: We identiﬁed 308,549 PTRA/S and 33,147 open
surgical repairs. PTRA/S increased from 1.9/100K adults in
1988 to 13.7 in 2006 followed by a decrease to 6.7 in 2009.
Open surgical repair steadily decreased from 1.3/100K
adults in 1988 to 0.3 in 2009. In 2009, PTRA/S procedures
(6.4/100K adults) greatly outnumbered procedures done by
open repair alone (0.1/100K), combined open renal and
aortic repair (0.2/100K), and combined PTRA/S and endo-
vascular aneurysm repair (0.3/100K). From 2005 to 2009
33,953 patients underwent PTRA/S in the states of New
Jersey Maryland, Florida, and California combined. The total
number of PTRA/S performed in the outpatient setting
remained stable from 2005 (3.8/100K) to 2009 (3.7/100K),
whereas the total number of inpatient procedures mirrored
the national trend, declining from 2006 (7.9/100K) to 2009
(4.2/100K). PTRA/S had lower in-hospital mortality (0.9% vs
4.1%; P < .001) compared with open repair. PTRA/S patients
were more likely to be discharged home (86.2% vs 76.3%;
P < .001) and had a shorter length of stay (4.4 vs 12.3 days;
P < .001). Mortality was higher after combined open renal
and open aortic surgery compared to open repair alone
(6.5% vs 4.1%; P < .001). Mortality was similar for combined
PTRA/S and endovascular aneurysm repair compared with
PTRA/S alone (1.2% vs 0.9%; P = .04).
Conclusions: The performance of PTRA/S procedures
for the management of RAS has decreased signiﬁcantly
after 2006. An increasing proportion of these pro-
cedures are performed in the outpatient setting. PTRA/
S remains the dominant revascularization procedure for
RAS with lower in-hospital mortality and morbidity
than surgery.
